Fig 1.
Flow diagram of the clinical trial.
Table 1.
Baseline characteristics of the study participants.
Table 2.
Puerperal characteristics of the study participants.
Fig 2.
Change in human milk volume over time.
Mean and 95% confidence intervals are presented. C, control group; D, domperidone group; T, herbal tea group.
Table 3.
Primary and secondary outcome measures for maternal complications, neonatal complications, and drug adverse events.
Table 4.
Secondary outcome measures for participant satisfaction.